Copyright
©The Author(s) 2017.
World J Hepatol. May 28, 2017; 9(15): 689-696
Published online May 28, 2017. doi: 10.4254/wjh.v9.i15.689
Published online May 28, 2017. doi: 10.4254/wjh.v9.i15.689
Studies | Year | Study type | Summary |
Setiawan et al[18] | 2015 | Prospective cohort | 2-3 cups/d noted to have 38% HCC reduction risk |
4 cups/d noted to have 41% risk reduction | |||
Yu et al[45] | 2013 | Prospective cohort | Significantly decreased risk of HCC noted among coffee drinkers |
Bravi et al[44] | 2013 | Meta-analysis (14 studies) | 40% HCC risk reduction with 1-3 cups coffee/day |
Bravi et al[43] | 2007 | Meta-analysis (10 studies) | Inverse association noted between coffee consumption and HCC |
Larsson et al[42] | 2007 | Meta-analysis (9 studies) | 43% HCC risk reduction |
Gelatti et al[28] | 2005 | Case control | Inverse relationship noted between coffee and HCC |
- Citation: Heath RD, Brahmbhatt M, Tahan AC, Ibdah JA, Tahan V. Coffee: The magical bean for liver diseases. World J Hepatol 2017; 9(15): 689-696
- URL: https://www.wjgnet.com/1948-5182/full/v9/i15/689.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i15.689